Paying users zone. Data is covered by 
.
Get 1-month access to Gilead Sciences Inc. for $17.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Gilead Sciences Inc. (GILD)
Analysis of Debt
Difficulty: Advanced
Total Debt (Carrying Amount)
Gilead Sciences Inc., balance sheet: debt
US$ in millions
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).
| Item | Description | The company |
|---|---|---|
| Total long-term debt (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Gilead Sciences Inc.’s total debt increased from 2016 to 2017 but then slightly declined from 2017 to 2018 not reaching 2016 level. |
Total Debt (Fair Value)
| Dec 31, 2018 | |
|---|---|
| Selected Financial Data (US$ in millions) | |
| Total long-term debt (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (filing date: 2019-02-26).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt:
| Interest Rate | Debt Amount1 | Interest Rate × Debt Amount | Weighted-average Interest Rate2 |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total | |
|
|
|
|||
Based on: 10-K (filing date: 2019-02-26).
1 US$ in millions
2 Weighted-average interest rate = 100 × ÷ =